Cumberland Pharma hopes for $115M in IPO

David P. Hamilton | July 26th, 2007

Cumberland Pharmaceuticals, a Nashville, Tenn., specialty pharmaceutical company with a hodgepodge of acquired products, priced its IPO and now hopes to raise as much as $115 million. The company plans to offer 6.25 million shares, plus a possible overallotment of 937,000 additional shares, at a price between $14 and $16 apiece. The offering would value Cumberland at as much as $403 million.

Tags: , ,
Sphere It Digg this story!
Trackback URL

  1. August 15th, 2007
    5:02 pm

    VentureBeat » Amgen grabs the axe, chops up to 2,600 jobs said:

    [...] will bring the first test in that regard: Cumberland Pharmaceuticals, which we noted briefly here, is due to launch its IPO sometime between now and [...]

  2. October 1st, 2007
    1:26 pm

    VentureBeat » Life sciences briefing: Friday, Sept. 21, 2007 said:

    [...] At that, Zars is in far better shape than Cumberland Pharmaceuticals, which has been expected to go public on a day-to-day basis since mid-August. We last wrote about Cumberland here. [...]